Mark Heffernan serves as Executive at Nexvet Biopharma plc, where they oversee executive responsibilities. Since joining the company, Mark Heffernan has executed 11 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 31, 2017 involved selling 243,587 shares valued at $1.6M.
Mark Heffernan currently holds 74,167 shares of Nexvet Biopharma plc (NVET), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Heffernan has been a net neutral trader of NVET stock. They have purchased $0 and sold $0 worth of shares.
Mark Heffernan's most recent insider trade was on Jul 31, 2017, when they sold 243,587 shares at $6.72 per share.
Get notified when new Form 4 filings are submitted
| 109,810 |
| $6.72 |
| Discretionary |
| Jul 1, 2017 | NVET | $3.3K | Option Exercise | 25,000 | $0.13 | Discretionary |
| Jul 1, 2017 | NVET | $4.6K | Option Exercise | 35,643 | $0.13 | Discretionary |
| Jul 1, 2016 | NVET | $628 | Option Exercise | 4,833 | $0.13 | Discretionary |
| Jul 1, 2016 | NVET | $3.3K | Option Exercise | 25,000 | $0.13 | Discretionary |
| Nov 23, 2015 | NVET | $943 | Option Exercise | 7,250 | $0.13 | Discretionary |
| Nov 20, 2015 | NVET | $1.2K | Option Exercise | 9,204 | $0.13 | Discretionary |
| Aug 20, 2015 | NVET | $628 | Award | 4,834 | $0.13 | Discretionary |
| Jun 8, 2015 | NVET | $943 | Award | 7,250 | $0.13 | Discretionary |
| Feb 10, 2015 | NVET | $0 | Conversion | 4,424 | $N/A | Discretionary |